Objectives: To determine the relationship between brachial blood pressure, and transfer function-estimated and invasively measured central aortic pressure in patients with at least moderate symptomatic aortic stenosis.

Methods: Fourteen patients aged 54-81 years with mean (SD) effective valve area of 0.69 (0.20) cm2, undergoing coronary angiography, had simultaneous peripheral and central aortic blood pressure measurements. Brachial blood pressure was determined by an oscillometric method. Aortic pressure was measured directly using pressure transducer tipped catheters, and estimated indirectly by the application of a transfer function to a radial arterial waveform obtained by tonometry.

Results: Measured aortic systolic pressure did not differ significantly from brachial pressure [mean difference (SD) 2 (9) mmHg, P = not significant (NS)]. Transfer function estimates of central systolic pressure obtained from the radial waveform calibrated from brachial pressure were less accurate [mean difference -8 (7) mmHg, P = 0.001]. Recalibration of the radial waveforms using the invasive mean and diastolic blood pressure improved the agreement [mean difference -2 (6) mmHg, P = NS] but did not provide a better estimate than brachial blood pressure. The accuracy of noninvasively estimated subendocardial viability ratio was substantially improved by recalibration of radial arterial waveforms using corrected ejection time.

Conclusion: In patients with aortic stenosis there is clinically acceptable agreement between noninvasive brachial pressure and directly measured central aortic pressure.

Download full-text PDF

Source
http://dx.doi.org/10.1097/HJH.0b013e328313919fDOI Listing

Publication Analysis

Top Keywords

blood pressure
24
central aortic
16
pressure
15
brachial blood
12
aortic pressure
12
brachial pressure
12
[mean difference
12
difference mmhg
12
aortic
9
aortic blood
8

Similar Publications

Individuals with severe mental illness (SMI) have a shorter life expectancy compared to the general population, largely due to cardiovascular disease (CVD). In this report from the Fixed Dose Intervention Trial of New England Enhancing Survival in SMI Patients (FITNESS), we examined baseline CVD risk factors and their treatment in patients with SMI and second generation antipsychotic (SGA) use. FITNESS enrolled 204 participants with SMI and SGA use, but without documented history of CVD or diabetes mellitus, from several clinics in the Boston, Massachusetts, area between April 29, 2015, and September 26, 2019.

View Article and Find Full Text PDF

Predictive parameters of cardiovascular risk in younger school-age children.

Cent Eur J Public Health

December 2024

Department of Public Health and Hygiene, Faculty of Medicine, Pavol Jozef Safarik University in Kosice, Kosice, Slovak Republic.

Objectives: Overweight and obesity are important concerns for global health. They are characterized by excessive fat accumulation that can harm health. Childhood obesity has reached alarming levels around the world due to urbanization and changes in lifestyle.

View Article and Find Full Text PDF

Objectives: This study aimed to determine the metabolic syndrome (MS) prevalence in a sample of adolescents, to calculate their continuous metabolic syndrome scores, and to determine the associations of continuous metabolic syndrome score with overweight/obesity and selected cardiometabolic and lifestyle factors.

Methods: We enrolled a sample of 2,590 adolescents (1,180 males, mean age 17.1 ± 1.

View Article and Find Full Text PDF

The aims of this study were to investigate the prevalence of cryofibrinogenemia in a cohort of patients with systemic sclerosis (SSc) regardless of clinical manifestations, who were admitted to our hospital and determine the associations among CF positivity, disease features and ongoing therapies. This was a monocentric and retrospective study. The inclusion criteria were a diagnosis of SSc (according to the ACR/EULAR 2013 classification criteria), regular administration of i.

View Article and Find Full Text PDF

Blood Pressure Control and Incident Left-Ventricular Conduction Disease.

Curr Cardiol Rep

January 2025

Division of Cardiology, Department of Medicine, University of California San Francisco, 505 Parnassus Ave, M1180B, San Francisco, CA, 94143, USA.

Purpose Of Review: Cardiac conduction disease, a harbinger of pacemaker implantation, heart failure, and death, is commonly regarded as immutable. However, emerging research suggests it may be a target for upstream prevention strategies such as blood pressure management. This review summarizes recent evidence regarding blood pressure control and the development of conduction disease.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!